Servier and Oncodesign Precision Medecines collaborate to develop new treatments for pancreatic cancer
Servier, an international pharmaceutical company, and Oncodesign Precision Medicine (OPM), a subsidiary of the Oncodesign biopharmaceutical group, ann...
30/09/2022
Read more →